Options Trading News

May 2, 2014  Fri 11:05 AM CT

Mallinckrodt reports earnings next week, and call selling sees limited upside in the Irish pharmaceutical company for the next several months.

A block of 3,250 October 80 calls was sold for the bid price of $5.10. This is clearly a new position, as open interest in the strike was just 515 contracts before the trade appeared.

These calls could have been sold naked with an initial bearish bias, but it is more likely that they were traded against a long-stock position in a covered-call strategy. The latter would be bullish up to $5.10 but not beyond, as the trader would be obligated to sell shares above that strike price. (See our Education section)

MNK is up 1.25 percent to $71.47 in midday trading after peaking at $72.62 earlier in the session, just off its high set in late February. Shares bounced off support at $60 three weeks ago.

The Dublin-based drug developer saw bullish option activity twice in the last month. The company is scheduled to announce quarterly results on May 8 before the market opens.
Share this article with your friends

Invest Like a Monster - San Antonio: October 9-10


The fastest money in the market
View full report »

Premium Services

Archived Webinar

Education & Strategy

Options Academy: More on the Covered Call Strategy

Last week, we talked about the Covered Call and the misconceptions that surround it. We spoke about how an investor must realize that the Covered Call is actually a premium collection strategy and not so much a directional one. If an investor can grasp this idea, the investor stands to do a heck of a lot better in the strategy than they currently do.

View more education articles »